Latest immunotherapy news
Cell Therapy MDR-101 Produces Functional Immune Tolerance in Kidney Transplant Recipients
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
posted July 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer
posted June 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Monjuvi for Relapsed, Refractory Follicular Lymphoma
posted June 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Childhood Cancer Survivors Often Have Mental Distress in Adulthood 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC Related Articles
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine Monthly Specialist Briefings
Stay Connected
